Biodexa strengthens management team - appointment of dr gary a. shangold as chief medical officer

January 22, 2025 biodexa strengthens management team appointment of dr gary a. shangold as chief medical officer biodexa pharmaceuticals plc (“biodexa” or “the company”), (nasdaq: bdrx), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announced today the appointment of dr gary a.
BDRX Ratings Summary
BDRX Quant Ranking